Chevy Chase Trust Holdings LLC Sells 10,220 Shares of MetLife, Inc. (NYSE:MET)

Chevy Chase Trust Holdings LLC lowered its stake in MetLife, Inc. (NYSE:MET) by 3.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 306,915 shares of the financial services provider’s stock after selling 10,220 shares during the quarter. Chevy Chase Trust Holdings LLC’s holdings in MetLife were worth $25,130,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also added to or reduced their stakes in the stock. MeadowBrook Investment Advisors LLC boosted its position in shares of MetLife by 244.4% during the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 220 shares during the last quarter. Carmichael Hill & Associates Inc. boosted its position in shares of MetLife by 131.9% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after acquiring an additional 186 shares during the last quarter. Wolff Wiese Magana LLC boosted its position in shares of MetLife by 374.3% during the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after acquiring an additional 277 shares during the last quarter. Peterson Financial Group Inc. purchased a new position in shares of MetLife during the 3rd quarter valued at about $30,000. Finally, Retirement Wealth Solutions LLC purchased a new position in shares of MetLife during the 4th quarter valued at about $32,000. Institutional investors own 94.99% of the company’s stock.

MetLife Price Performance

MET opened at $81.78 on Friday. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.16 and a current ratio of 0.16. MetLife, Inc. has a 52-week low of $67.30 and a 52-week high of $89.05. The stock has a market capitalization of $56.63 billion, a PE ratio of 13.70, a price-to-earnings-growth ratio of 0.64 and a beta of 1.07. The stock’s 50 day moving average price is $83.47 and its 200-day moving average price is $81.01.

MetLife (NYSE:MET) last posted its earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. On average, equities research analysts predict that MetLife, Inc. will post 9.63 EPS for the current year.

MetLife Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th will be paid a dividend of $0.545 per share. The ex-dividend date is Tuesday, February 4th. This represents a $2.18 annualized dividend and a dividend yield of 2.67%. MetLife’s dividend payout ratio (DPR) is presently 36.52%.

Analysts Set New Price Targets

MET has been the topic of a number of research reports. TD Cowen raised their price objective on MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a report on Wednesday, November 27th. BMO Capital Markets initiated coverage on MetLife in a report on Thursday, January 23rd. They set a “market perform” rating and a $97.00 price objective on the stock. Wells Fargo & Company decreased their price objective on MetLife from $93.00 to $92.00 and set an “overweight” rating on the stock in a report on Tuesday, January 14th. JPMorgan Chase & Co. raised their price objective on MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a report on Tuesday, January 7th. Finally, Keefe, Bruyette & Woods decreased their price objective on MetLife from $100.00 to $98.00 and set an “outperform” rating on the stock in a report on Wednesday. Two equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $92.17.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.